Evan Kransdorf
Overview
Explore the profile of Evan Kransdorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jordan E, Ni H, Parker P, Kinnamon D, Owens A, Lowes B, et al.
medRxiv
. 2024 Dec;
PMID: 39649582
Background: Clinical genetic evaluation of dilated cardiomyopathy (DCM) is implemented variably or not at all. Identifying needs and barriers to genetic evaluations will enable strategies to enhance precision medicine care....
2.
Manla Y, Chang D, Patel J, Kanungo A, Nikolova A, Kransdorf E, et al.
J Heart Lung Transplant
. 2024 Nov;
PMID: 39561862
Background: Primary graft dysfunction (PGD) remains the leading cause of 30-day mortality post-heart transplantation (HTx). HTx recipients experiencing severe PGD have been found to have high levels of circulating proteins...
3.
Mukherjee S, Maleszewski J, Luthringer D, Confer M, Mittal A, Dasari S, et al.
Circulation
. 2024 Oct;
150(16):1299-1301.
PMID: 39401277
No abstract available.
4.
Miller R, Shanbhag A, Marcinkiewicz A, Struble H, Fujito H, Kransdorf E, et al.
medRxiv
. 2024 Oct;
PMID: 39399046
Purpose: [18F]-fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET) plays a central role in diagnosing and managing cardiac sarcoidosis. We propose a fully automated pipeline for quantification of [18F]FDG PET activity using...
5.
Fedrigo M, Berry G, Coutance G, Reed E, Lin C, Giarraputo A, et al.
Am J Transplant
. 2023 Oct;
24(4):533-541.
PMID: 37838218
The Banff Heart Concurrent Session, held as part of the 16th Banff Foundation for Allograft Pathology Conference at Banff, Alberta, Canada, on September 21, 2022, focused on 2 major topics:...
6.
Dhillon M, Kobashigawa J, Kittleson M, Jain R, Patel N, Singer-Englar T, et al.
Clin Transplant
. 2023 Oct;
38(1):e15165.
PMID: 37837612
Background: The use of bortezomib which is a proteasome inhibitor has been demonstrated to be efficacious in small number of patients as a desensitization strategy in heart transplant. We reviewed...
7.
Han J, Rushakoff J, Moayedi Y, Henricksen E, Lee R, Luikart H, et al.
J Heart Lung Transplant
. 2023 Oct;
43(3):387-393.
PMID: 37802261
Methods: Consecutive adult HT recipients (n = 596) from 1/2015 to 12/2019 at 2 US centers were included. Severity of PGD was based on the 2014 International Society for Heart...
8.
Hofmeyer M, Haas G, Jordan E, Cao J, Kransdorf E, Ewald G, et al.
Circulation
. 2023 Aug;
148(11):872-881.
PMID: 37641966
Background: Dilated cardiomyopathy (DCM) can lead to advanced disease, defined herein as necessitating a durable left ventricular assist device or a heart transplant (LVAD/HT). DCM is known to have a...
9.
Jordan E, Kinnamon D, Haas G, Hofmeyer M, Kransdorf E, Ewald G, et al.
JAMA
. 2023 Aug;
330(5):432-441.
PMID: 37526719
Importance: Black patients with dilated cardiomyopathy (DCM) have increased familial risk and worse outcomes than White patients, but most DCM genetic data are from White patients. Objective: To compare the...
10.
Ni H, Jordan E, Kinnamon D, Cao J, Haas G, Hofmeyer M, et al.
J Am Coll Cardiol
. 2023 May;
81(21):2059-2071.
PMID: 37225358
Background: Cardiovascular screening is recommended for first-degree relatives (FDRs) of patients with dilated cardiomyopathy (DCM), but the yield of FDR screening is uncertain for DCM patients without known familial DCM,...